GLIPR1 Peptide
| Code | Size | Price |
|---|
| PSI-7623P-0.05mg | 0.05mg | £166.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Target Species: Human
Documents
Further Information
Additional Names:
GLIPR, RTVP1, CRISP7, GLIPR, Glioma pathogenesis-related protein 1, Protein RTVP-1, GliPR 1
Application Note:
The peptide is used for blocking the activity of GLIPR1 antibody (catalog number 7623). It usually blocks the antibody activity completely by incubating the peptide with equal volume of antibody for 30 min at 37˚C.
Background References:
- Murphy EV, Zhang Y, Zhu W, et al. The human glioma pathogenesis-related protein is structurally related to pathogenesis-related proteins and its gene is expressed specifically in brain tumors. Gene 1995; 159:131-5.
Buffer:
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Concentration:
200 ug/mL
NCBI Gene ID #:
11010
NCBI Official Name:
GLI pathogenesis-related 1
NCBI Official Symbol:
GLIPR1
NCBI Organism:
homo sapiens
Peptide aa Location:
18 amino acids near the center of human GLIPR1.
Physical State:
Liquid
Protein Accession #:
NP_006842
Protein GI Number:
110825980
Swissprot #:
P48060